company background image
BOUL logo

Boule Diagnostics OM:BOUL Voorraadrapport

Laatste prijs

SEK 7.38

Marktkapitalisatie

SEK 286.6m

7D

4.5%

1Y

-26.2%

Bijgewerkt

22 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Boule Diagnostics AB (publ)

OM:BOUL Voorraadrapport

Marktkapitalisatie: SEK 286.6m

BOUL Overzicht aandelen

Boule Diagnostics AB (publ) ontwikkelt, produceert en verkoopt instrumenten en verbruiksartikelen voor bloeddiagnostiek in de Verenigde Staten, Azië, Oost-Europa, Latijns-Amerika, West-Europa, Afrika en het Midden-Oosten. Meer informatie

Boule Diagnostics AB (publ) Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Boule Diagnostics
Historische aandelenkoersen
Huidige aandelenkoersSEK 7.38
52 Week HoogtepuntSEK 12.62
52 Week LaagSEK 6.50
Bèta0.48
11 maand verandering-3.66%
3 maanden verandering-9.56%
1 Jaar Verandering-26.20%
33 jaar verandering-85.64%
5 jaar verandering-88.82%
Verandering sinds IPO-37.06%

Recent nieuws en updates

Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Oct 10
Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jul 25
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Jul 24
Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Recent updates

Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Oct 10
Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jul 25
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Jul 24
Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Jun 06
Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

May 10
Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Mar 20
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Feb 09
Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Dec 30
Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Jul 25
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

May 26
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Jul 26
Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

Jul 19
Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Mar 06
We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Feb 03
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Apr 29
The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Apr 09
Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Mar 25
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Mar 07
Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

Feb 17
Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Jan 30
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

Jan 14
Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Dec 28
How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Dec 10
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Nov 22
What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Rendement voor aandeelhouders

BOULSE Medical EquipmentSE Markt
7D4.5%-2.6%-0.2%
1Y-26.2%-6.3%11.8%

Rendement versus industrie: BOUL presteerde slechter dan de Swedish Medical Equipment -sector, die het afgelopen jaar een rendement van -7.8 % opleverde.

Rendement versus markt: BOUL presteerde slechter dan Swedish Market, dat het afgelopen jaar een rendement van 10.9 % opleverde.

Prijsvolatiliteit

Is BOUL's price volatile compared to industry and market?
BOUL volatility
BOUL Average Weekly Movement7.7%
Medical Equipment Industry Average Movement7.4%
Market Average Movement5.5%
10% most volatile stocks in SE Market11.3%
10% least volatile stocks in SE Market3.3%

Stabiele aandelenkoers: BOUL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 8% ) van BOUL is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1956200Torben Nielsenwww.boule.com

Boule Diagnostics AB (publ) ontwikkelt, produceert en verkoopt instrumenten en verbruiksartikelen voor bloeddiagnostiek in de Verenigde Staten, Azië, Oost-Europa, Latijns-Amerika, West-Europa, Afrika en het Midden-Oosten. Het bedrijf levert hematologie-analysatoren, reagentia, controles en kalibrators onder de merknamen Swelab, Medonic en Quintus; en veterinaire hematologie- en klinisch-chemische analysesystemen, evenals reagentia en panels onder de merknaam Exigo. Het bedrijf levert aan kleine en middelgrote ziekenhuizen, klinieken, laboratoria, dierenklinieken en andere diagnostische bedrijven.

Boule Diagnostics AB (publ) Samenvatting

Hoe verhouden de winst en inkomsten van Boule Diagnostics zich tot de beurswaarde?
BOUL fundamentele statistieken
MarktkapitalisatieSEK 286.59m
Inkomsten(TTM)-SEK 212.52m
Inkomsten(TTM)SEK 563.33m

0.5x

P/S-verhouding

-1.3x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
BOUL resultatenrekening (TTM)
InkomstenSEK 563.33m
Kosten van inkomstenSEK 309.02m
BrutowinstSEK 254.31m
Overige uitgavenSEK 466.84m
Inkomsten-SEK 212.52m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

Feb 11, 2025

Winst per aandeel (EPS)-5.47
Brutomarge45.14%
Nettowinstmarge-37.73%
Schuld/Eigen Vermogen Verhouding64.3%

Hoe presteerde BOUL op de lange termijn?

Bekijk historische prestaties en vergelijking